Proud to Partner With:
Expertise Partner:
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems
to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal and metabolic diseases and oncology.
Event Partner:
Gubra offers expert preclinical research services enabling pharmaceutical and biotech companies to advance their drug development pipeline. Our capabilities in preclinical studies include in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. We employ a combination of unique techniques to profile drug
candidates in a wide array of clinically translatable research models.
Innovation Partner:
Physiogenex is a preclinical CRO providing original and benchmarked animal models of obesity/type 2 diabetes and related co-morbidities: NASH, dyslipidemia, inflammation, diabetic nephropathy, HFpEF and atherosclerosis. For >20 years, we have been evaluating the efficacy of our clients’ drugs using gold-standard experiments in our validated preclinical models. Our customers benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners. Our expertise – your success.